Applications invited for free MBBS and BDS seats at Yenepoya University

Bengaluru, Jan 6: Students and teachers from various colleges in Bengaluru gathered at the Town Hall in the city to protest against the violence which broke out at the Jawaharlal Nehru University (JNU) campus in New Delhi on January 5.

The students raised slogans against Home Minister Amit Shah and Delhi Police.

Placards that read 'The more you attack, the stronger we become', 'Take off your masks terrorist', 'With JNU' were seen during the protest.

"We are here to protest against the incident that took place at JNU with our brothers and sisters. What Delhi Police did was shameful and they should have taken charge of the situation long before and not waited for three hours. We stand with JNU," Nisha, a protestor told ANI.

Professors present at the protest expressed regret over the incident and said attacks on the universities is a sick situation in the country.

"This is sick, where have we come to -- violence in the universities? I was so safe when I was studying in college; what we are giving to our students is horrible," said Sangeeta, a professor present at the protest.

Politicians, cutting across party lines, have condemned the attack on students in JNU and demanded strict action against those found guilty.

More than 18 students were taken to the AIIMS Trauma Centre after a masked mob entered the JNU campus and attacked them and some professors with sticks and rods.

Bengaluru, Apr 22: In order to infuse confidence among people to fight against the COVID-19 pandemic, Karnataka government on Wednesday launched a helpline 'Apthamitra' with an exclusive toll free number and a mobile app, aimed at providing required medical advice and guidance for those in need.

The help line and app was launched by Chief Minister B S Yediyurappa in the presence of senior Ministers and officials of the department.

Speaking on the occasion, Mr Yediyurappa said that the help line was need at this crucial juncture. “If anyone has symptoms of Coronavirus, they can call the helpline from their home, get medical advice or assistance and get their doubts cleared. 

People who call to know the symptoms, an expert team of doctors will advice on what to do next.”

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.